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Abstract
Introduction: Since persulfate salts are an important cause of occupational asthma (OA), we aimed to study the persistence
of respiratory symptoms after a single exposure to ammonium persulfate (AP) in AP-sensitized mice.
Material and Methods: BALB/c mice received dermal applications of AP or dimethylsulfoxide (DMSO) on days 1 and 8. On
day 15, they received a single nasal instillation of AP or saline. Airway hyperresponsiveness (AHR) was assessed using
methacholine provocation, while pulmonary inflammation was evaluated in bronchoalveolar lavage (BAL), and total serum
immunoglobulin E (IgE), IgG1 and IgG2a were measured in blood at 1, 4, 8, 24 hours and 4, 8, 15 days after the single
exposure to the causal agent. Histological studies of lungs were assessed.
Results: AP-treated mice showed a sustained increase in AHR, lasting up to 4 days after the challenge. There was a
significant increase in the percentage of neutrophils 8 hours after the challenge, which persisted for 24 hours in AP-treated
mice. The extent of airway inflammation was also seen in the histological analysis of the lungs from challenged mice. Slight
increases in total serum IgE 4 days after the challenge were found, while IgG gradually increased further 4 to 15 days after
the AP challenge in AP-sensitized mice.
Conclusions: In AP-sensitized mice, an Ig-independent response is induced after AP challenge. AHR appears immediately,
but airway neutrophil inflammation appears later. This response decreases in time; at early stages only respiratory and
inflammatory responses decrease, but later on immunological response decreases as well.
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Introduction
Occupational asthma (OA) is one of the most common forms of
lung-related occupational diseases in Europe, and its annual
incidence is increasing. It is estimated that 10% to 25% of all adult
onset asthma cases are work-related or caused by occupational
exposure [1,2]. More than 400 agents have been reported to cause
asthma in the workplace [3]. These agents can be divided into two
groups according to their molecular weight: high-molecular-
weight (HMW) or low-molecular-weight (LMW) [4]. Persulfate
salts are LMW chemicals widely used in various manufacturing
processes [5], especially in bleaching hair products, and are
capable of causing immunological sensitization and subsequently
allergic diseases such as contact dermatitis and asthma. Persulfate
salts are acknowledged as the main cause of OA amongst
hairdressing professionals [6–10].
However, the mechanisms by which these substances induce
sensitization and OA are not yet clear as the processes seem to
differ from the typical IgE-mediated allergic response. Previously,
our research group demonstrated that AP is able to induce an
asthma-like response in a validated mouse model of chemical-
induced asthma. In these studies, several features of human OA
were induced, such as airway hyperresponsiveness (AHR),
neutrophilic inflammation, increased levels of total serum immu-
noglobulin E (IgE), along with T and B cell proliferation and
increased levels of IL-4, IL-10 and IL-13, one day after intranasal
instillation of ammonium persulfate (AP) [11,12].
At present, the measure most commonly implemented to avoid
OA-induced symptoms is complete removal from workplace
exposure [13]. However, there is insufficient scientific evidence
to assert that cessation of exposure improves asthma symptoms
[14]. It has been shown that in the case of complete avoidance of
exposure, fewer than 1/3 of workers with OA recover from their
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symptoms [15–17]. Reduced exposure has been suggested as a
possible alternative to full cessation, with the aim of minimizing
the adverse socio-economic effects. However, a recent systematic
review reports that reduced exposure seems to be less beneficial
than removal of the patient from the workplace [15].
In the case of persulfate salts, it is not known how patients
evolve once they avoid exposure to the causal agent. Only one
study has described the course of AHR and immunological
outcome parameters in patients with OA due to persulfate salts.
Despite the persistence of asthma symptoms and AHR in these
patients, the study reported an improvement in their condition if
exposure was ceased [18].
The aim of the present study was to examine the persistence of
the asthmatic response after a specific AP challenge in AP-
sensitized mice [11]. AHR, lung inflammation and immune
response were evaluated at different time intervals after intranasal
instillation of AP in dermally sensitized mice.
Materials and Methods
Animals
Male BALB/c mice (,20 g, 6 weeks old) were obtained from
Harlan (Horst; The Netherlands). The mice were housed in filter
top cages in a conventional animal house with 12 h dark/light
cycles and received slightly acidified water and pelleted food
(Teklad 2014, Harlan Laboratories, Indianapolis, IN) ad libitum.
All experimental procedures were approved by the Ethical
Committee for Animal Experiments of Hospital Universitari Vall
d’Hebron.
Mouse model of persulfate salt-induced asthma
On days 1 and 8, all groups of mice received dermal
applications of 5% ammonium persulfate (AP, [(NH4)2S2O8],
Sigma-Aldrich, Steinheim, Germany) or vehicle (dimethylsulfoxide
(DMSO), Sigma-Aldrich, Steinheim, Germany) on both ears
(20 ml). On day 15, under light anaesthesia with isoflurane
(Forane, Abbott Laboratories, Madrid, Spain), they received
40 ml of 1% AP or vehicle (saline, 0.9%NaCl) via intranasal
instillation (challenge). The experimental groups were DMSO/
SAL and DMSO/AP, identified as control groups, and AP/AP
identified as the treatment group: the first abbreviation referring to
dermal sensitizations (days 1 and 8) and the second to the agent
administered via intranasal instillation (day 15). Each group of
mice (controls and treatment) consisted of 4–7 animals for each
period of time after intranasal instillation: 1 hour, 4 hours,
8 hours, 24 hours (day 16), 4 days (day 19), 8 days (day 23) and
15 days (day 30). The experiments were repeated twice per group.
Pulmonary function measurement
Airway hyperresponsiveness. After intranasal instillation,
reactivity to methacholine was assessed invasively using a forced
oscillation technique (FOT) with FlexiVent system (Flexivent,
SCIREQ; Montreal, Canada) at each time point (1 hour, 4 hours,
8 hours, 24 hours, 4 days, 8 days and 15 days). Mice were deeply
anaesthetised by an intraperitoneal injection of pentobarbital
(70 mg/kg) (Nembutal, Abbot Laboratories). The trachea was
exposed and tracheotomised, and connected to a ventilator
controlled by computer. Airway resistance (R) was measured with
a ‘‘snapshot’’ protocol and plotted against methacholine concen-
tration (from 0 to 10 mg/ml) and the Area Under the Curve
(AUC) was calculated [19].
Total Serum Immunoglobulins (IgE, IgG1 and IgG2a)
After the methacholine test was assessed, blood was taken by
cardiac puncture and pooled (before BAL). Serum samples were
obtained and stored at 280uC for further analyses. The Mouse
ELISA kits (Bethyl Laboratories, Inc., Montgomery, USA) were
used to measure total serum IgE, IgG1 and IgG2a (diluted samples
1/5, 1/12500 and 1/5000, respectively). Measurements were
performed according to the manufacturer’s instructions, using
biotinylated antimouse IgE, IgG1 and IgG2a detection antibodies
and horseradish peroxidise conjugate.
Bronchoalveolar lavage
After blood sampling, bronchoalveolar lavage (BAL) was
performed. The lungs were lavaged three times with 0.7 ml of
sterile saline (0,9% NaCl) and the recovered fluid was pooled.
Total cells were counted using a haemocytometer and the BAL
fluid was centrifuged (1000 g, 10 minutes). The supernatant was
frozen (280uC) until further analyses. For differential cell counts,
250 ml of the resuspended cells (100 000 cells/ml; 1400 g, 6
minutes) were spun (Cytospin 3, Shandon, Thermo Scientific,
Cheshire, United Kingdom) onto microscope slides, air-dried and
stained [May-Gru¨nwald, 5 min (QCA; Tarragona, Spain) and
Giemsa, 15 min (Merck, Darmstadt, Germany)]. Counts for the
number of macrophages, eosinophils, neutrophils and lymphocytes
were performed in 500 cells from each sample.
Levels of interferon-gamma (IFN-c) and interleukins-2 (IL-2),
IL-4, IL-5, IL-10, IL-13 and IL-17A were measured in the first
fraction of undiluted BAL fluid by a mouse cytokine magnetic
bead panel according to the manufacturer’s instructions (Bio-Plex
Pro Mouse Cytokine Group I 7-plex Assay, Bio-Rad Laboratories
S.A.; Madrid, Spain). Lower limits of detection were 1.56, 3.41,
6.11, 1.85, 1.26, 4.00, 3.02 pg/mL for IFN-c, IL-2, IL-4, IL-5, IL-
10, IL-13 and IL-17A, respectively.
Measurement of Th2 related cytokines in homogenized
lung tissue
After performing BAL, the left lung was removed and
homogenized with 500 ml of BSA/PBS 5%. The homogenate
was centrifuged (3000 g, 10 min) and levels of cytokines were
measured in the supernatant. The pellet was dried and weighed.
Concentrations of IL-2, IL-4, IL-5, IL-13, IL-10, and IL-17A were
measured using a Cytometric Bead Array Plex (Bio-Plex Pro
Mouse Cytokine Group I 7-plex Assay, Bio-Rad Laboratories
S.A.; Madrid, Spain). Measured concentrations were corrected for
the lung dry weight. Lower limits of detection were 3.41, 6.11,
1.85, 1.26, 4.00, 3.02 pg/mL for IL-2, IL-4, IL-5, IL-10, IL-13
and IL-17A, respectively.
Lung pathology
After BAL, lungs were instilled with formaldehyde 3.7–4.0%
until all lobes were deemed to be fully inflated by visual inspection.
Evaluation of lung injury on slides stained by haematoxylin and
eosin (H&E) and Masson’s trichrome was performed by an
experienced pathologist in a blinded manner. A semi-quantitative
scoring system was used to grade the severity and extent of
inflammation on haematoxylin-eosin stained sections. We graded
the thickness of the infiltrate in the interalveolars septa using as
follows: 0 (normal) = absence of inflammatory cells; 1 (mild) = 1–2
layers of inflammatory cells; 2 (moderate) = 3–5 layers; 3
(severe) =more than 5 layers.
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Data analysis
All data are presented as mean 6 standard error of the mean
(SEM) and were analysed using the non-parametric Kruskal-
Wallis test and Mann-Whitney U-test (Graphpad Prism 4.01,
Graphpad Software Inc, San Diego, USA). A level of p,0.05
(two-tailed) was considered significant.
Results
Airway hyperresponsiveness to methacholine
To assess the course of airway hyperresponsiveness (AHR) to
methacholine, AUC was calculated for each individual mouse in
each experimental group. The airway resistance to methacholine
assessed 1 hour after the challenge was significantly increased in
AP/AP mice compared with control groups assessed at the same
time. This response remained increased until 4 days after
inhalation (figure 1). Additionally, significant differences in early
AHR (1–8 hours) were found in DMSO/PA groups compared
with DMSO/SAL groups. At the later time points (8 and 15 days
after the challenge) no significant increases in AHR to methacho-
line were found.
Pulmonary inflammation (bronchoalveolar lavage)
No differences were found in the total cell count in any of
groups assessed at any time point. There was a quick response in
the total number of neutrophils found 8 hours after the AP
challenge in AP-treated mice compared with the control group
(DMSO/SAL), which persisted until 24 hours post-inhalation
(figure 2B). There were no eosinophils in BAL samples from any of
the groups.
Measurement of the cytokines mentioned in BAL fluid revealed
increases in IL-10 levels 4 h after AP challenge and increases in
IL-2 and IL-13 levels 4 days after AP challenge in the group of AP-
sensitized mice, although statistical significance was not reached
(p = 0.053, p= 0.076 and p= 0.083, respectively) (figure 3).
Neither levels of IL-4, IL-5, nor IL-17A were detected in BAL
samples. Cytokine levels were not detectable in tissue homogenate
except for IL5, although no significant differences observed
between the groups.
Total serum immunoglobulins (IgE, IgG1 and IgG2a)
Figure 4A shows the levels of total serum IgE at the different
time points assessed. AP/AP-treated mice showed significant
increases in total serum IgE 4 days after the challenge compared
with control groups. However, 8 and 15 days after the challenge
no significant differences were found compared with controls, and
IgE levels returned to baseline values. Total serum IgG1 increased
significantly from 4 to 15 days after the AP challenge (figure 4B),
while total serum IgG2a was significantly increased in AP-treated
mice 4 days after the challenge (figure 4C).
Airway histopathology
A blinded histopathological examination of lung tissue sections
from the AP/AP mice assessed 8 hours after AP challenge
revealed mild to moderate inflammatory cell infiltration and
presence of alveolar macrophages compared with control groups.
Selectively, at 4 days after the challenge, some moderate
peribronchiolar epithilium hyperplasia was observed in the AP/
AP group compared with control groups (figure 5A). In this acute
single challenge model, no collagen deposition was found, as
shown in the lung sections stained with Masson’s trichrome
Figure 1. Airway hyperresponsiveness (AHR) to methacholine expressed as resistance (R) was measured 1 hour, 4 hours, 8 hours,
24 hours, 4 days, 8 days and 15 days after intranasal instillation by the forced oscillation technique to increasing concentrations of
methacholine. Experimental groups were DMSO/SAL, DMSO/AP and AP/AP. First abbreviation refers to dermal sensitization (day 1 and 8), and the
second to the agents administered via intranasal instillation (day 15). A) Mean 6 SEM of AUC of R against methacholine concentrations (0 to 10 mg/
ml) for all periods of time. B) Mean individual values of AUC 1 hour, 24 hours, 4 days and 15 days after challenge. *p,0.05, **p,0.01 compared with
DMSO/SAL, ++p,0.01 compared with DMSO/AP, Yp,0.05 and YYp,0.01 when DMSO/SAL is compared with DMSO/AP. No significant differences
were found in the other groups studied at different time intervals. AP, ammonium persulfate; AUC, area under the curve; DMSO, dimethylsulfoxide;
SAL, saline.
doi:10.1371/journal.pone.0109000.g001
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Figure 2. Total number of macrophages (A), neutrophils (B) and lymphocytes (C) in BAL obtained 1, 4, 8 and 24 hours, and 4, 8 and
15 days after AP challenge. Experimental groups are the same as figure 1. Mean6 SEM of total number of neutrophils in BAL. *p,0.05 compared
with DMSO/SAL, +p,0.05 compared with DMSO/PA. No significant differences were found in the other groups studied at different time points. AP,
ammonium persulfate, BAL, bronchoalveolar lavage, DMSO, dimethylsulfoxide; SAL, saline.
doi:10.1371/journal.pone.0109000.g002
Figure 3. Levels of interleukin (IL)-2, IL-10 and IL-13 in BAL fluid. BAL samples were collected 1, 4, 8 and 24 hours, and 4, 8 and 15 days after
AP challenge. Experimental groups are the same as figure 1. A) Mean 6 SEM of IL-13 concentration. B) Mean6 SEM of IL-10 concentration. C) Mean
6 SEM of IL-2 concentration. Y: p = 0.083 compared with DMSO/SAL, p: p = 0.053 compared with DMSO/SAL, V: p = 0.055 compared with DMSO/AP,
j: p = 0.076 compared with DMSO/SAL. No significant differences were found in the other groups studied at different time intervals. AP, ammonium
persulfate; BAL, bronchoalveolar lavage; DMSO, dimethylsulfoxide; IL, interleukin; SAL, saline.
doi:10.1371/journal.pone.0109000.g003
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(figure 5B). Scoring of stained lung sections illustrates that in AP/
AP mice there was an increase in inflammatory cells between 1
and 24 h after challenge (Grade 1, mild), with a maximum at 4
days (Grade 2, moderate). In the DMSO/PA group there was an
increase in inflammatory cells 1 hour after challenge (Grade 1,
mild) that disappear 4 hours after challenge. No inflammation was
observed in the control group.
Discussion
The present study shows that, in dermally sensitized mice, after
exposure to persulfate salts the asthmatic response peaks early after
the challenge, and then decreases gradually over time. A reduction
in the inflammatory response is observed early, while decreases in
airway hyperresponsiveness (AHR) and immunological response
occur later on.
Our data show a persistent AHR up to 4 days after intranasal
challenge with ammonium persulfate (AP). However, although
AHR persisted for several days, a significant increase in
pulmonary inflammation was only found within 24 hours after
the challenge, with inflammatory cells reaching their peak after
8 hours as shown in both BAL samples and histopathological
sections. So there was a clear dissociation in time between AHR
and inflammatory response. This type of dissociation between
Figure 4. Total serum immunoglobulin (Ig)-E, IgG1 and IgG2a. Blood was collected 1, 4, 8 and 24 hours, and 4, 8 and 15 days after
AP challenge. Total serum IgE, IgG1 and IgG2a were measured using a standard ELISA. Experimental groups are as in figure 1. A) Mean 6 SEM of
total serum IgE. B) Mean 6 SEM of total serum IgG1. C) Mean 6 SEM of total serum IgG2a. *p,0.05, **p,0.01 compared with DMSO/SAL, +p,0.05
compared with DMSO/PA. No significant differences were found in the other groups studied at different time intervals. AP, ammonium persulfate;
DMSO, dimethylsulfoxide; SAL, saline.
doi:10.1371/journal.pone.0109000.g004
Figure 5. Lung histopathology. Representative images of lung sections are shown at low and high magnification. A) Haematoxylin and eosin
stained histological lung sections. B) Massons’s trichrome stained histological lung sections. Experimental groups in this figure are represented with
sections from DMSO/SAL, DMSO/AP groups and AP/AP groups assessed 8 hours and 4 days after AP challenge. AP, ammonium persulfate, DMSO,
dimethylsulfoxide; SAL, saline.
doi:10.1371/journal.pone.0109000.g005
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inflammation and AHR has been described in previous studies of
patients with asthma. In a study in which the effects of anti-IL-5
were evaluated in patients refractory to high doses of inhaled
corticosteroids, a reduction in the number of eosinophils in sputum
was observed, but no changes in pulmonary function or AHR
were found [20]. Kariyawasam et al. [21] studied the involvement
of inflammation and airway remodelling in the pathogenesis of
AHR. After antigen challenge, in asthmatic patients with a late
response, the increased airway inflammation 24 hours after
challenge had returned to baseline values after seven days, while
increases in AHR and remodelling biomarkers like RBM
procollagen III, procollagen I and expression of HSP-47 persisted
at this time point. This dissociation in time between AHR and
lung inflammation has also been reported in several animal models
[22,23]. The results of these studies suggest that AHR may be the
result of independent factors in which inflammation does not have
such a relevant direct role. Recently, Hox et al. [24], observed
AHR without bronchial inflammation after an intranasal chal-
lenge with ClO- followed by an ovalbumin challenge in mice. The
authors concluded that this AHR is independent of the classic
adaptive immunity mechanism. They showed that the induction of
AHR may depend on a neuroimmune interaction involving both
mast cell activation and the transient receptor potential ankyrin
(TRPA)1-dependent stimulation of sensory neurons. This mech-
anism could explain why the group of non-sensitized mice which
received the AP challenge (DMSO/AP) showed early AHR in the
present study. In this group, this AHR was not accompanied by an
increased number of neutrophils or increased levels of total serum
IgE, as happened with the asthmatic groups (AP/AP), demon-
strating a possible regulation by a nonspecific irritant mechanism
in this case [24–26]. It is known that LMW agents elicit an
asthmatic response later than HMW agents. Consequently, the
early AHR in the previously sensitized asthmatic groups may also
be due to this possible irritant effect of the causal agent.
In this model of OA, peak levels of total serum IgE were found 4
days after AP challenge. In some studies in patients with OA due
to persulfate salts, the latent period between the exposure and the
onset of symptoms and the type of response observed when the
challenge test is assessed suggest that OA induced by persulfate
salts is mediated by an immunological mechanism [8–10]. Positive
skin-prick tests for persulfate salts have been reported, suggesting
that this immunological mechanism may be mediated by IgE
[8,9,27,28]. Nevertheless, the possible role of IgE in persulfate salt-
induced OA has not been well established.
Increased levels of IL-2, IL-10 and IL-13 in BAL fluid and IL-5
in tissue homogenate in AP-treated mice were observed after AP
exposure, which suggests a mixed Th1-Th2-type immune response
in sensitized mice. IL-13 is known for its central role in both IgE
production and induction of AHR in allergic humans and mice
[29] a finding that is borne out by the results obtained in this
study. IL-10 is a cytokine with broad anti-inflammatory properties
and has an important role in the regulation of Th2 responses [30].
In an experimental study of allergen exposure in sensitized
asthmatic patients, spontaneous increases in the levels of IL-10
produced by ex vivo sputum cells were reported [31]. Conse-
quently, the increase observed in the concentration of IL-10 in
BAL samples in this study may be due to a compensatory
mechanism for the allergic response which occurs after exposure.
Finally, IL-2 a typical Th1 cytokine is also linked to the
maintenance of Th2 cells, among other activities [32].
A mixed Th1-Th2 response was found not only in BAL
cytokines, but also in serum. In this model, both IgE and IgG1
were increased at selected time points. This finding was already
reported in another model of chemical-induced asthma
[11,19,33]. In this study, levels of total serum IgG2a showed the
same trend as IgE and remained increased 4 days after AP
challenge. While IgE is a typical Th2 response, IgG2a is
characteristic of a Th1 immune response. Other animal models
using LMW agents to induce asthma have shown similar results in
the form of increased levels of serum IgG2a [33,34]. There is also
evidence of this mixed Th1-Th2 immune response in these
animals in view of the cytokine profile in cells in the local draining
lymph nodes, since the sensitizer compound caused an increase in
both Th1-Th2 cytokines [11,33,35].
As reported above after the initial peak response, total serum
IgE returned to baseline values one week after the challenge.
Changes in the levels of total serum IgG1 did not follow the same
pattern: total serum IgG1 increased significantly from the fourth
day post-challenge and persisted over the two weeks of the
experiment. These results are consistent with other studies with
animal models of asthma induced by LMW agents, which showed
increased total levels of serum IgG (IgG1 and IgG2a) [33,36,37].
The role of IgG in response to occupational agents is even more
complex. Immunological sensitization to LMW agents is often for
life and levels of specific IgG may persist for many years [4]. This
IgG persistence was also observed by Vanoirbeek et al., based on
animal models of OA due to LMW agents [33]. It has been
suggested that IgG1 may be important for monitoring the effect of
exposure to LMW agents, and particularly to isocyanates, before
the onset of the condition [38], although we did not confirm this
possible role in our study. Furthermore, it has been reported that
an increase in levels of serum IgG, which matches with the
decrease of the AHR and inflammatory response, may have a
protective effect in this model of OA [39]. Recent studies with
asthmatic patients showed a progressive increase in IgG levels with
prolonged exposure to allergens [40,41].
To our knowledge, this is the first study to assess the persistence
of systemic and ventilatory responses in an animal model of OA
due to persulfate salts after the end of exposure to the causal agent.
Our experiments show that the progressive decrease in the
asthmatic response over time observed in mice may mirror that in
patients with OA when exposure to the causal agent ceases [14].
However, many of these patients do not completely recover from
their asthmatic symptoms [17], supporting the notion that
complete removal from the workplace is not more likely to avoid
symptoms than continued exposure [14]. In this context, the
mouse model described in this study shows evidence that animals
exhibit systemic sensitization which makes them susceptible to
developing a new asthmatic response when they are re-exposed to
the causal agent. This finding has implications for the recurrence
of asthma symptoms.
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